Abstract
Cardiovascular diseases are the leading cause of death in western countries. Therapeutic advances with the development of cardiovascular drugs have led to great advances in the prognosis of patients with heart disease.The development of drugs that drastically reduce the low-density lipoprotein cholesterol, or antidiabetics that have become a main pillar in the treatment of heart failure, take us to a very attractive horizon in the management and control of cardiovascular risk factors and patients with heart disease.In this article we review a few recent cardiovascular drugs very useful for the clinical cardiologist, without neglecting the importance of therapeutic adherence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
